cancer

Burnout Hits Oncologists Hard, but Healthcare Systems Can Help
Burnout Hits Oncologists Hard, but Healthcare Systems Can HelpHealthcare systems stand to lose $6 million if burned out physicians choose to resign or work elsewhere. Here are some ways to curb burnout and its associated costs.
How RA, Cancer, Hep C Drug Costs Will Change Over Next Five Years
How RA, Cancer, Hep C Drug Costs Will Change Over Next Five YearsExperts weigh in on the spending outlook for these high-cost conditions.
FDA approves revolutionary blood cancer treatmentFDA’s approval of a new combination treatment for patients with classical Hodgkin lymphoma (cHL) is the first new advanced treatment for the disease in 40 years
Global Genetic-Based Database Ramps UpThe new global DNA registry could help enable more precise treatments and identify who’s at risk for certain health problems.
Improve Care Coordination in Cancer Care: 2 Key Focus AreasWhen caring for cancer patients, improving care coordination in these two areas is key—and it can help reduce healthcare costs.
Top 3 new cancer drugs
Top 3 new cancer drugsThe first radioactive drug to treat a certain type of cancer is among the top 3 new drug approvals for cancer. Here are the other top cancer drug approvals so far in 2018.
Seven diseases benefiting from genetic tests
Seven diseases benefiting from genetic testsGenetic testing is playing a growing role in diagnosing and treating diseases, particularly when it comes to certain cancers and rheumatic conditions.
New modeling addresses heart disease in childhood cancer survivorsNew predictive models may identify and help childhood cancer survivors at a higher risk for ischemic heart disease and stroke.
What Roche’s Purchase of Flatiron Health Means for Health ExecsSwitzerland-based pharma company Roche’s $1.9 billion purchase of tech company Flatiron Health signifies Big Pharma’s need for data.
Two Ways to Take Charge of CAR T-Cell Therapy CostsSuccessful CAR T-cell therapy reimbursement begins with careful payer-provider collaboration and taking these two approaches.